Executive Summary
The June 25, 2026, insider trading filings reveal a market dominated by routine compensation awards and passive position reporting, masking several high-conviction signals. The most significant event is a massive $248M sale by Mantle Ridge LP in **DOLLAR TREE, INC.**, a 10% owner, which represents a major bearish signal for the discount retail sector.
Conversely, open-market buying is scarce but notable, with two directors at **Sixth Street Lending Partners** making small, coordinated purchases, and a 10% owner at **MEXICO FUND INC** adding to a position. The period is marked by several planned insider sales under 10b5-1 plans at **Sea Ltd**, **Global-E Online**, **GALECTIN THERAPEUTICS**, **Monte Rosa Therapeutics**, and **PC CONNECTION**, indicating pre-arranged diversification. A cluster of director stock awards at **HYDROFARM HOLDINGS GROUP** and **Foghorn Therapeutics** suggests a focus on board retention. The overall sentiment is mixed, with a bearish tilt from large-scale selling and a lack of bullish open-market buying, but the prevalence of neutral compensation events tempers the negative outlook.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: Form 4
Tracking the trend? Catch up on the prior USA Insider Trading Pulse digest from June 18, 2026.
Investment Signals (10)
- DOLLAR TREE, INC. ↓ (BEARISH)▲
10% owner Mantle Ridge LP sold 2.23M shares (~$248M), reducing its stake by 17.6% to 10.48M shares. This is the largest single transaction by value and signals a major loss of confidence from a key activist investor.
- Monte Rosa Therapeutics ↓ (BEARISH)▲
CMO Janku Filip sold 30,000 shares (~$643K) in a 10b5-1 plan, exercising options at $7.56 and selling at $21.42. The 183% profit-taking on a biotech stock with no approved products is a bearish signal from a top executive.
- Sixth Street Lending Partners ↓ (BULLISH)▲
Two directors (Tanemura Ronald and HIGGINBOTHAM RICHARD A) made open-market purchases totaling 1,426 shares (~$41K) at $28.81. This coordinated insider buying at a consistent price is a rare bullish signal for a BDC.
- MEXICO FUND INC ↓ (BULLISH)▲
10% owner Saba Capital Management added 20,151 shares (~$433K) at ~$21.40, increasing its stake. This is a bullish vote of confidence in a closed-end fund trading at a potential discount.
- Sea Ltd ↓ (BEARISH)▲
COO Ye Gang sold 4,324 shares (~$396K) across 11 trades under a 10b5-1 plan. While planned, the systematic selling by a top executive is a bearish signal for the high-growth tech sector.
- UNITED NATURAL FOODS INC ↓ (BEARISH)▲
President Bushway Mark sold 10,000 shares (~$516K), reducing his holdings by 16.4%. This is a significant insider sale by a division president, suggesting caution on the natural foods distributor's near-term outlook.
- PC CONNECTION INC ↓ (BEARISH)▲
Chairman & CAO GALLUP PATRICIA sold 6,576 shares (~$461K) under a 10b5-1 plan. The sale of a large block by the chairman is a notable bearish signal for the IT solutions provider.
- GALECTIN THERAPEUTICS INC ↓ (BEARISH)▲
CMO Jamil Khurram exercised options at $1.23 and immediately sold the shares at $3.14 (~$24K). This same-day exercise-and-sell pattern is a bearish signal, indicating the executive is monetizing options rather than holding the stock.
- WEIBO Corp ↓ (BULLISH)▲
CEO Wang Gaofei acquired 374,791 ADS, increasing his holdings by 51%. This is a strong bullish signal from the CEO of a Chinese social media company, suggesting confidence in the company's valuation and prospects.
- Global-E Online Ltd. ↓ (BEARISH)▲
President Debbi Nir sold 6,890 shares (~$234K) under a 10b5-1 plan. While planned, the sale by a president of a high-growth cross-border e-commerce company is a bearish signal.
Risk Flags (8)
- DOLLAR TREE / Activist Exit↓ [HIGH RISK]▼
Mantle Ridge LP's $248M sale is a high-risk flag. The 10% owner's aggressive reduction could signal a loss of faith in the turnaround strategy or an expectation of near-term underperformance. Watch for further sales.
- Monte Rosa Therapeutics / CMO Profit-Taking↓ [HIGH RISK]▼
CMO Janku Filip sold 100% of his exercisable options, converting 30,000 shares and selling all of them. This complete liquidation of a top executive's option position is a red flag for a pre-revenue biotech.
- Sea Ltd / Systematic Insider Selling↓ [MEDIUM RISK]▼
COO Ye Gang's 11 separate sales in a single day, even under a 10b5-1 plan, suggest a deliberate strategy to reduce exposure. The pattern of selling is a risk for the stock's momentum.
- GALECTIN THERAPEUTICS / Same-Day Exercise & Sale↓ [MEDIUM RISK]▼
CMO Jamil Khurran's exercise-and-sell pattern shows no intention to hold the stock, indicating a lack of long-term conviction from a key executive.
- UNITED NATURAL FOODS / Division President Sale↓ [MEDIUM RISK]▼
President Bushway Mark's 16.4% reduction in holdings is a risk flag for the natural foods segment, potentially signaling operational challenges or margin pressure.
- PC CONNECTION / Chairman Sale↓ [MEDIUM RISK]▼
Chairman GALLUP PATRICIA's sale of 6,576 shares, while under a plan, is a risk flag given her position and the size of the transaction (~$461K).
- ▼
Saba Capital Management sold 111,896 shares (~$1.71M). This is a risk flag for the closed-end fund, as a major holder is reducing exposure.
- CITIZENS FINANCIAL SERVICES / EVP Sale↓ [LOW RISK]▼
EVP Gephart LeeAnn sold 29 shares (~$1.9K). While small in value, any insider sale by a bank executive is a risk flag to monitor for broader sector concerns.
Opportunities (8)
- Sixth Street Lending Partners / Director Buying↓ (OPPORTUNITY)◆
Two directors bought shares at $28.81, a price point they find attractive. This is a rare bullish signal for a BDC, suggesting the stock is undervalued.
- WEIBO Corp / CEO Accumulation↓ (OPPORTUNITY)◆
CEO Wang Gaofei's 51% increase in holdings is a powerful vote of confidence. This could signal that the company's turnaround or growth strategy is on track, presenting a buying opportunity.
- MEXICO FUND INC / Activist Accumulation↓ (OPPORTUNITY)◆
Saba Capital Management, a known activist in closed-end funds, is increasing its stake. This often precedes a push for strategic actions like a tender offer or liquidation, creating value for shareholders.
- Foghorn Therapeutics / Director Option Grants↓ (OPPORTUNITY)◆
Three directors were awarded 28,000 stock options each at $4.08. This low strike price aligns director interests with shareholders and suggests the board sees significant upside potential from current levels.
- HYDROFARM HOLDINGS GROUP / Board Alignment↓ (OPPORTUNITY)◆
Four directors were awarded 30,000 shares each, increasing their alignment with shareholders. This is a positive signal for a small-cap company, indicating board commitment.
- Chagee Holdings Ltd. / COO Option Exercise↓ (OPPORTUNITY)◆
COO Yin Dengfeng exercised 80,427 ADS options at $3.76 (~$303K), increasing his stake. This exercise, even without a sale, shows confidence in the tea beverage company's future.
- NEOGENOMICS INC / Director Award↓ (OPPORTUNITY)◆
Director Starrett Carolyn S was awarded both 9,784 stock options and 14,125 RSUs. This dual-award structure is a strong retention and incentive tool, signaling board confidence in the company's growth trajectory.
- ORIX CORP / Insider Buying↓ (OPPORTUNITY)◆
Two officers (Otsuka Takashi and Matsuzaki Satoru) made small open-market purchases at $38.22. While small, any open-market buying by Japanese executives is a positive signal for the diversified financial conglomerate.
Sector Themes (5)
- Biotech Insider Profit-Taking◆
Two biotech executives (GALECTIN THERAPEUTICS and Monte Rosa Therapeutics) executed same-day option exercises and sales, cashing out on gains. This pattern suggests a lack of long-term conviction in pre-revenue biotech stocks, a bearish theme for the sector.
- Closed-End Fund Activist Activity◆
Saba Capital Management is active on both sides, buying MEXICO FUND INC and selling BlackRock ESG Capital Allocation Term Trust. This suggests a tactical, fund-specific approach rather than a broad sector view, creating opportunities in funds where they are accumulating.
- Planned Insider Selling Dominates◆
Multiple 10b5-1 plan sales (Sea Ltd, Global-E Online, GALECTIN THERAPEUTICS, Monte Rosa Therapeutics, PC CONNECTION) indicate that executives are systematically reducing exposure. This is a broad bearish signal for the growth and small-cap segments.
- Director Compensation Awards Surge◆
A high volume of director stock and option awards (HYDROFARM, Foghorn, NEOGENOMICS, ACACIA RESEARCH, VirnetX) suggests a focus on board retention and alignment. This is a neutral-to-positive signal for corporate governance.
- Lack of Broad-Based Open-Market Buying◆
Outside of a few isolated instances (Sixth Street Lending Partners, ORIX CORP, WEIBO Corp), there is a notable absence of bullish open-market insider buying. This is a cautious signal for the overall market, suggesting insiders are not aggressively buying the dip.
Watch List (8)
-
Watch for further 13D filings or additional sales. The activist's next move could signal a proxy fight or a complete exit. Immediate.
-
Monitor for additional 10b5-1 plan sales by CMO Janku Filip. If he continues to sell, it will confirm the bearish signal. Next filing expected within 2 days.
-
Watch for any deviation from the 10b5-1 plan by COO Ye Gang. An acceleration of sales would be a stronger bearish signal. Ongoing.
-
Monitor for any subsequent sales by CEO Wang Gaofei after his large acquisition. If he holds, it confirms the bullish signal. Ongoing.
-
Watch for additional open-market purchases by directors Tanemura or HIGGINBOTHAM. Continued buying would be a strong bullish signal. Ongoing.
-
After the director awards, watch for any insider sales. If directors hold the awarded shares, it signals confidence. Next 30 days.
-
Monitor for further sales by Saba Capital Management. A continued reduction could pressure the fund's share price. Ongoing.
-
Watch for a Schedule 13D filing from Saba Capital Management, which would signal an activist intent. A filing could be a catalyst for the stock. Next 10 days.
Filing Analyses
(50)
25-06-2026
Director Kato Mami acquired 2,000 Share-based Compensation Points.
- · Director Kato Mami acquired 2,000 Share-based Compensation Points
25-06-2026
Chief Executive Officer Wang Gaofei acquired 374,791 ADS. Wang Gaofei holds 1,106,627 shares after the transaction.
- · Chief Executive Officer Wang Gaofei acquired 374,791 ADS
25-06-2026
COO Ye Gang sold 4,324 Class A ordinary shares at $91.69 (~$396K). 11 transactions reported in total. Ye Gang holds 600,000 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · COO Ye Gang sold 800 Class A ordinary shares at $87.90 (~$70.3K)
- · COO Ye Gang sold 1,600 Class A ordinary shares at $89.02 (~$142K)
- · COO Ye Gang sold 1,000 Class A ordinary shares at $89.93 (~$89.9K)
- · COO Ye Gang sold 2,276 Class A ordinary shares at $91.03 (~$207K)
- · COO Ye Gang sold 4,324 Class A ordinary shares at $91.69 (~$396K)
- · COO Ye Gang sold 1,733 Class A ordinary shares at $90.68 (~$157K)
- · COO Ye Gang sold 1,296 Class A ordinary shares at $91.52 (~$119K)
- · COO Ye Gang sold 2,846 Class A ordinary shares at $92.62 (~$264K)
25-06-2026
Director Hodo Chikatomo acquired 2,000 Share-based Compensation Points.
- · Director Hodo Chikatomo acquired 2,000 Share-based Compensation Points
25-06-2026
See Remarks Irie Shuji acquired 37,370 Share-based Compensation Points.
- · See Remarks Irie Shuji acquired 37,370 Share-based Compensation Points
25-06-2026
See Remarks Otsuka Takashi bought 13.159 Common Stock at $38.22 (~$503). Otsuka Takashi holds 2,332.494 shares after the transaction.
- · See Remarks Otsuka Takashi bought 13.159 Common Stock at $38.22 (~$503)
- · See Remarks Otsuka Takashi acquired 15,750 Share-based Compensation Points
25-06-2026
See remarks Yamada Masataka acquired 37,370 Share-based Compensation Points.
- · See remarks Yamada Masataka acquired 37,370 Share-based Compensation Points
25-06-2026
Director Seki Miwa acquired 2,000 Share-based Compensation Points.
- · Director Seki Miwa acquired 2,000 Share-based Compensation Points
25-06-2026
See remarks Suzuki Yoshiteru acquired 37,370 Share-based Compensation Points.
- · See remarks Suzuki Yoshiteru acquired 37,370 Share-based Compensation Points
25-06-2026
See remarks Takahashi Hidetake acquired 81,560 Share-based Compensation Points.
- · See remarks Takahashi Hidetake acquired 81,560 Share-based Compensation Points
25-06-2026
See remarks Matsuzaki Satoru bought 6.579 Common Stock at $38.22 (~$251). Matsuzaki Satoru holds 10,719.053 shares after the transaction.
- · See remarks Matsuzaki Satoru bought 6.579 Common Stock at $38.22 (~$251)
- · See remarks Matsuzaki Satoru acquired 51,910 Share-based Compensation Points
25-06-2026
Director Yanagawa Noriyuki acquired 2,000 Share-based Compensation Points.
- · Director Yanagawa Noriyuki acquired 2,000 Share-based Compensation Points
25-06-2026
Executive Officer Ishihara Tomohiko bought 3.947 Common Stock at $38.22 (~$151). Ishihara Tomohiko holds 382.674 shares after the transaction.
- · Executive Officer Ishihara Tomohiko bought 3.947 Common Stock at $38.22 (~$151)
- · Executive Officer Ishihara Tomohiko acquired 11,960 Share-based Compensation Points
25-06-2026
Director Watanabe Hiroshi acquired 2,000 Share-based Compensation Points.
- · Director Watanabe Hiroshi acquired 2,000 Share-based Compensation Points
25-06-2026
EXECUTIVE VICE PRESIDENT Gephart LeeAnn sold 29 COMMON CLASS at $66.52 (~$1.93K). Gephart LeeAnn holds 808 shares after the transaction.
- · EXECUTIVE VICE PRESIDENT Gephart LeeAnn sold 29 COMMON CLASS at $66.52 (~$1.93K)
25-06-2026
President, Natural & CSCO Bushway Mark sold 10,000 Common Stock at $51.56 (~$516K). Bushway Mark holds 51,119 shares after the transaction.
- · President, Natural & CSCO Bushway Mark sold 10,000 Common Stock at $51.56 (~$516K)
25-06-2026
President Debbi Nir sold 6,890 Ordinary Shares at $34.02 (~$234K). Debbi Nir holds 4,547,961 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · President Debbi Nir sold 6,890 Ordinary Shares at $34.02 (~$234K)
25-06-2026
10% owner Saba Capital Management, L.P. bought 15,051 Common Stock at $21.52 (~$324K). Saba Capital Management, L.P. holds 2,260,134 shares after the transaction.
- · 10% owner Saba Capital Management, L.P. bought 15,051 Common Stock at $21.52 (~$324K)
- · 10% owner Saba Capital Management, L.P. bought 5,100 Common Stock at $21.31 (~$109K)
25-06-2026
Director Clark Todd J. reported beneficial ownership in UMH PROPERTIES, INC.. 2 positions reported.
- · Holds 5,848.56 UMH Properties, Inc. (direct)
- · Holds 12,000 UMH Properties, Inc. (direct)
25-06-2026
Director QUIGLEY KENNETH K JR reported beneficial ownership in UMH PROPERTIES, INC.. 5 positions reported.
- · Holds 44,809.83 UMH Properties, Inc. (direct)
- · Holds 11,000 UMH Properties,Inc. (direct)
- · Holds 10,000 UMH Properties,Inc. (direct)
- · Holds 12,000 UMH Properties,Inc. (direct)
- · Holds 12,000 UMH Properties,Inc. (direct)
25-06-2026
Director Levy Stuart reported beneficial ownership in UMH PROPERTIES, INC.. 5 positions reported.
- · Holds 30,287.75 UMH Properties, Inc. (direct)
- · Holds 11,000 UMH Properties, Inc. (direct)
- · Holds 10,000 UMH Properties, Inc. (direct)
- · Holds 12,000 UMH Properties, Inc. (direct)
- · Holds 12,000 UMH Properties, Inc. (direct)
25-06-2026
Director Mitchell William Edward reported beneficial ownership in UMH PROPERTIES, INC.. 5 positions reported.
- · Holds 34,065.47 UMH Properties, Inc. (direct)
- · Holds 11,000 UMH Properties, Inc. (direct)
- · Holds 10,000 UMH Properties, Inc. (direct)
- · Holds 12,000 UMH Properties, Inc. (direct)
- · Holds 12,000 UMH Properties, Inc. (direct)
25-06-2026
Director Cordella Richard James JR exercised/converted 3,791 Common Stock. Cordella Richard James JR holds 4,291 shares after the transaction.
- · Director Cordella Richard James JR exercised/converted 3,791 Common Stock
- · Director Cordella Richard James JR exercised/converted 3,701 RSU - Time Vested Award
25-06-2026
Director HIRSCH MATTHEW I reported beneficial ownership in UMH PROPERTIES, INC.. 6 positions reported.
- · Holds 63,585.57 UMH Properties, Inc. (direct)
- · Holds 5,748.19 UMH Properties, Inc. (indirect)
- · Holds 11,000 UMH Properties, Inc. (direct)
- · Holds 10,000 UMH Properties, Inc. (direct)
- · Holds 12,000 UMH Properties, Inc. (direct)
- · Holds 12,000 UMH Properties, Inc. (direct)
25-06-2026
10% owner Saba Capital Management, L.P. sold 111,896 Common Stock at $15.25 (~$1.71M). Saba Capital Management, L.P. holds 18,042,176 shares after the transaction.
- · 10% owner Saba Capital Management, L.P. sold 91,365 Common Stock at $15.37 (~$1.4M)
- · 10% owner Saba Capital Management, L.P. sold 111,896 Common Stock at $15.25 (~$1.71M)
25-06-2026
Mantle Ridge LP sold 2,230,455 Common Stock, par value $0.01 per share at $111.31 (~$248M). Mantle Ridge LP holds 10,476,208 shares after the transaction.
- · Mantle Ridge LP sold 2,230,455 Common Stock, par value $0.01 per share at $111.31 (~$248M)
25-06-2026
Chairman JONAS HOWARD S gifted 2,217 Class B Common Stock, $.01 par value per share. JONAS HOWARD S holds 46,553 shares after the transaction.
- · Chairman JONAS HOWARD S gifted 2,217 Class B Common Stock, $.01 par value per share
25-06-2026
Director Tanemura Ronald bought 856 Common shares of beneficial interest, par value $0.001 at $28.81 (~$24.7K). Tanemura Ronald holds 13,740 shares after the transaction.
- · Director Tanemura Ronald bought 856 Common shares of beneficial interest, par value $0.001 at $28.81 (~$24.7K)
25-06-2026
SVP, GC and Secretary Boyle Robert was awarded 53 Common Stock. Boyle Robert holds 35,772 shares after the transaction.
- · SVP, GC and Secretary Boyle Robert was awarded 53 Common Stock
25-06-2026
VP and Chief Tech. Officer Anderson Todd L was awarded 33 Common Stock. Anderson Todd L holds 31,081 shares after the transaction.
- · VP and Chief Tech. Officer Anderson Todd L was awarded 33 Common Stock
25-06-2026
Director KILAR JASON was awarded 19,446 Restricted Stock Units.
- · Director KILAR JASON was awarded 19,446 Restricted Stock Units
25-06-2026
EVP, CFO & Treasurer Fennerty Conor was awarded 49,326 Common Stock. Fennerty Conor holds 209,014 shares after the transaction.
- · EVP, CFO & Treasurer Fennerty Conor was awarded 49,326 Common Stock
25-06-2026
Director Bisharat Jaleh was awarded 19,446 Restricted Stock Units.
- · Director Bisharat Jaleh was awarded 19,446 Restricted Stock Units
25-06-2026
EVP & Chief Investment Officer Cattonar John M was awarded 45,051 Common Stock. Cattonar John M holds 183,189 shares after the transaction.
- · EVP & Chief Investment Officer Cattonar John M was awarded 45,051 Common Stock
25-06-2026
Director Starrett Carolyn S was awarded 9,784 Stock Option (Right to Buy).
- · Director Starrett Carolyn S was awarded 9,784 Stock Option (Right to Buy)
- · Director Starrett Carolyn S was awarded 14,125 Restricted Stock Unit
25-06-2026
Director Yetter Richard Christopher was awarded 30,000 Common Stock, $0.0001 par value per share. Yetter Richard Christopher holds 50,000 shares after the transaction.
- · Director Yetter Richard Christopher was awarded 30,000 Common Stock, $0.0001 par value per share
25-06-2026
Director Lynch Thomas J. Jr. was awarded 28,000 Stock Options (Right to buy) at $4.08 (~$114K).
- · Director Lynch Thomas J. Jr. was awarded 28,000 Stock Options (Right to buy) at $4.08 (~$114K)
25-06-2026
Chief Medical Officer Jamil Khurram sold 7,557 Common Stock at $3.14 (~$23.7K). Jamil Khurram holds 7,557 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Chief Medical Officer Jamil Khurram exercised/converted 7,557 Common Stock at $1.23 (~$9.3K)
- · Chief Medical Officer Jamil Khurram sold 7,557 Common Stock at $3.14 (~$23.7K)
- · Chief Medical Officer Jamil Khurram exercised/converted 7,557 Stock option (right to buy)
25-06-2026
Director FELMAN MICHELLE was awarded 25,052 ACTG Common Stock. FELMAN MICHELLE holds 57,224 shares after the transaction.
- · Director FELMAN MICHELLE was awarded 25,052 ACTG Common Stock
25-06-2026
Director Duty Stuart was awarded 28,000 Stock Options (Right to buy) at $4.08 (~$114K).
- · Director Duty Stuart was awarded 28,000 Stock Options (Right to buy) at $4.08 (~$114K)
25-06-2026
Chief Operating Officer Yin Dengfeng exercised/converted 80,427 American Depositary Shares at $3.76 (~$303K). Yin Dengfeng holds 347,653 shares after the transaction.
- · Chief Operating Officer Yin Dengfeng exercised/converted 80,427 American Depositary Shares at $3.76 (~$303K)
- · Chief Operating Officer Yin Dengfeng exercised/converted 80,427 Employee Stock Options (Right to buy)
25-06-2026
Director Chung Patrick was awarded 30,000 Common Stock, $0.0001 par value per share. Chung Patrick holds 91,148 shares after the transaction.
- · Director Chung Patrick was awarded 30,000 Common Stock, $0.0001 par value per share
25-06-2026
Chairman & Chief Admin Officer GALLUP PATRICIA sold 6,576 Common Stock at $70.04 (~$461K). 4 transactions reported in total. GALLUP PATRICIA holds 7,013,463 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Chairman & Chief Admin Officer GALLUP PATRICIA sold 2,275 Common Stock at $69.23 (~$157K)
- · Chairman & Chief Admin Officer GALLUP PATRICIA sold 4,867 Common Stock at $69.96 (~$340K)
- · Chairman & Chief Admin Officer GALLUP PATRICIA sold 6,576 Common Stock at $70.04 (~$461K)
- · Chairman & Chief Admin Officer GALLUP PATRICIA sold 566 Common Stock at $70.52 (~$39.9K)
25-06-2026
Director Persofsky Renah was awarded 30,000 Common Stock, $0.0001 par value per share. Persofsky Renah holds 91,498 shares after the transaction.
- · Director Persofsky Renah was awarded 30,000 Common Stock, $0.0001 par value per share
25-06-2026
President and CEO LANDY SAMUEL A reported beneficial ownership in UMH PROPERTIES, INC.. 9 positions reported.
- · Holds 1,000,967.76 UMH Properties, Inc. (direct)
- · Holds 12,189.5 UMH Properties, Inc. (indirect)
- · Holds 41,403.87 UMH Properties, Inc. (indirect)
- · Holds 52,401.86 UMH Properties, Inc. (indirect)
- · Holds 48,000 UMH Properties, Inc. (indirect)
- · Holds 29,500 UMH Properties, Inc. (direct)
- · Holds 50,000 UMH Properties, Inc. (direct)
- · Holds 50,000 UMH Properties, Inc. (direct)
25-06-2026
Chief Medical Officer Janku Filip sold 30,000 Common Stock at $21.42 (~$643K). 6 transactions reported in total. Janku Filip holds 59,992 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Chief Medical Officer Janku Filip exercised/converted 6,000 Common Stock at $7.56 (~$45.4K)
- · Chief Medical Officer Janku Filip sold 11,845 Common Stock at $20.22 (~$240K)
- · Chief Medical Officer Janku Filip exercised/converted 30,000 Common Stock at $7.56 (~$227K)
- · Chief Medical Officer Janku Filip sold 30,000 Common Stock at $21.42 (~$643K)
- · Chief Medical Officer Janku Filip exercised/converted 6,000 Stock Option (Right to Buy)
- · Chief Medical Officer Janku Filip exercised/converted 30,000 Stock Option (Right to Buy)
25-06-2026
Director O'BRIEN THOMAS M was awarded 7,500 Common Stock. O'BRIEN THOMAS M holds 35,457 shares after the transaction.
- · Director O'BRIEN THOMAS M was awarded 7,500 Common Stock
25-06-2026
Director Denis Melisa was awarded 30,000 Common Stock, $0.0001 par value per share. Denis Melisa holds 88,423 shares after the transaction.
- · Director Denis Melisa was awarded 30,000 Common Stock, $0.0001 par value per share
25-06-2026
Director Biller Scott was awarded 28,000 Stock Options (Right to buy) at $4.08 (~$114K).
- · Director Biller Scott was awarded 28,000 Stock Options (Right to buy) at $4.08 (~$114K)
25-06-2026
Director HIGGINBOTHAM RICHARD A bought 570 Common shares of beneficial interest, par value $0.001 at $28.81 (~$16.4K). HIGGINBOTHAM RICHARD A holds 9,416 shares after the transaction.
- · Director HIGGINBOTHAM RICHARD A bought 570 Common shares of beneficial interest, par value $0.001 at $28.81 (~$16.4K)
Get daily alerts with 10 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 50 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: USA Insider Trading Pulse
🇺🇸 More from United States
View all →June 18, 2026
US Pre-Market SEC Filings Roundup — June 18, 2026
US Pre-Market SEC Filings Roundup
June 18, 2026
US Merger & Acquisition SEC Filings — June 18, 2026
US Merger & Acquisition SEC Filings
June 17, 2026
US Pre-Market SEC Filings Roundup — June 17, 2026
US Pre-Market SEC Filings Roundup
June 17, 2026
US Merger & Acquisition SEC Filings — June 17, 2026
US Merger & Acquisition SEC Filings